Objectives: Application of a HPLC (high performance liquid chromatography) method, using cyanide derivatisation, to the determination of plasma pyridoxal-5-phosphate (PLP) concentrations as an indicator of vitamin B 6 adequacy. Setting: The study was performed at the Institute of Food Research, Norwich, UK. Blood samples were taken at the Institute, at Health Centres, or in the volunteer's home. Subjects: 51 adolescent, 131 adult, 68 non-institutionalized elderly and 44 aged ( b 73 y) volunteers were recruited from local authority schools, local Health Centres and General Practitioners. Results: The mean PLP recovery was 92.8%. The intra-and inter-assay coef®cients of variation were 2.8% and 5.2% respectively. Mean PLP concentrations for males and females, respectively, were: adolescents (13 ± 14 y), 36.4 and 43.5 nM; adults (20 ± 64 y), 39.2 and 40.0 nM; elderly (68 ± 73 y), 34.8 and 35.3 nM; aged ( b 73 y), 57.8 and 49.0 nM. Percentages of subjects with PLP concentrations`34.4 nM were over 26% in all population groups. Mean vitamin B 6 intakes (mgag protein intake), as assessed by weighed dietary records, were all above reference nutrient intakes (15 mgag protein). Conclusions: An HPLC method, using cyanide derivitisation, has been applied to the determination of plasma PLP. Comparisons of results for local population groups with current cut-off values for plasma PLP, show large numbers of volunteers at risk of vitamin B 6 de®ciency although this is not re¯ected by vitamin B 6 intakes calculated from food tables. The 34.4 nM cut-off value for value for plasma PLP, indicating de®ciency, is questioned.
Introduction
Vitamin B 6 (active 3-hydroxy-2-methylpyridine derivatives) is an essential precursor for the pyridoxal-5-phosphate (PLP) coenzyme for protein and, to a lesser extent, carbohydrate and lipid metabolism. More recently a range of additional roles have been suggested for this vitamin: (i) prevention of atherosclerorosis (Murray & Pizzorno, 1990a; Vermaak et al, 1987; Ubbink, 1994; Verhoef & Stampfer, 1995; Selhub et al, 1993) ; (ii) optimization of immune function (Rall & Meydani, 1993) ; (iii) treatment of premenstrual tension (PMT) (Murray & Pizzorno, 1990b; Kleijnen, et al, 1991) ; (iv) prevention of nausea and vomiting during pregnancy (Vir et al, 1980; Guilarte, 1993; (v) learning and memory (Guilarte, 1993; Kleijnen & Knipschild, 1991) ; (vi) alteration of steroid hormone responsiveness, and thus, the aetiology and treatment of certain cancers and hypertension (Bender, 1994) ; (vii) treatment of psychiatric patients (Sandyk & Pardeshi, 1990; Bender, 1992; Stewart et al, 1984) .
The total body pool of vitamin B 6 is around 200 mg (Coburn et al, 1988 ) (Note: not 20 ± 30 mg as quoted by Gibson, 1990) . About 70 ± 80% of this pool is in skeletal muscle and is resistant to depletion, reducing only after 6 weeks of low intake (1.76 mmolad; 0.37 mgad pyridoxine hydrochloride) in adult males (Coburn et al, 1991) . However, the major transport form of vitamin B 6 is PLP, which declines relatively rapidly at low dietary intake. Thus, measurement of this active coenzyme form of vitamin B 6 in plasma is more likely to re¯ect short-term intake than muscle B 6 which is tightly bound to glycogen phosphorylase and only turns over as this enzyme does (Coburn et al, 1991) . Low plasma concentrations of PLP, therefore, do not re¯ect muscle concentration but may provide a good indication of de®ciency risk.
Biochemical methods, developed over the last twenty years for the determination of PLP concentrations in biological samples, include microbiological, spectrophotometric,¯uorometric, enzymatic, radio-enzymatic, and chromatography (Sauberlich, 1984 , Vanderslice et al, 1985 Leklem, 1990) . No single method has been recommended for determination of vitamin B 6 adequacy (Leklem, 1990; Li & Lumeng, 1980; Bender, 1993) .
Separation of PLP from other B 6 vitamins is easily achieved by high performance liquid chromatography (HPLC), but detection has to be achieved by formation of UV absorbing,¯uorescent or electrochemically active derivatives, since PLP has only low intrinsic¯uorescence. The dif®culty with HPLC methods for the determination of plasma PLP has been their lack of sensitivity, since plasma PLP concentrations are typically in the 5 ± 100 ngaml (20.3 ± 405 nM) range, necessitating relatively large sample sizes (0.3 ± 1.0 ml) (Sauberlich, 1984) .
The use of cyanide to produce a highly¯uorescent derivative of PLP was ®rst used in 1959 (Ohishi & Fukui, 1968 , Adams, 1969 , Tamura & Takanaski, 1970 and enabled more sensitivity than other derivatives. Cyanide derivatisation of PLP was used in combination with HPLC in methods by Naoi et al (1988) , who determined PLP concentrations in puri®ed enzymes, human brain homogenates and tissue cultured cells, but not human plasma.
In the present paper, a method based on that of Naoi et al (1988) was used to measure PLP concentrations in small (100 ml) volumes of plasma. This method facilitates studies where small samples may be important, for example studies involving very young volunteers, or when a single sample needs to be used for a variety of biochemical assays. Minor modi®cations to the method are described and reproducibility and recovery data are presented, together with ranges of PLP concentrations found in human adolscent adult, elderly and aged population groups. The incidence of vitamin B 6 de®ciency, as judged by currently used cut-off value for plasma PLP, was determined. How appropriate these cut-off values are, as indicators of de®ciency, is considered.
Materials and methods

Reagents
All reagents were analytical grade unless speci®ed otherwise. Pyridoxal-5-phosphate (PLP) and 4-pyridoxic acid (PA) were obtained from Sigma Chemical Co, Dorset, UK. All water was double glass distilled. Potassium cyanide was obtained from Sigma Chemical Co. (Dorset, UK). Pyridoxine (PN), Pyridoxal (PL), pyridoxamine (PM) and pyridoxamine-5-phosphate were also obtained from Sigma Chemical Company.
Pyridoxal-5-phosphate and 4-pyridoxic acid standards A stock PLP solution (50 mgaml; 202.3 mM in 10 mM potassium phosphate buffer, pH 7.4) was prepared freshly each week and stored at 4 C in the dark. Working standard solutions were prepared daily by dilution of the stock 25 mgal (0.1 mM) in 10 mM phosphate buffer.
For the additional determination of pyridoxic acid (PA), a stock solution of PA (100 mgal; 0.546 mM) was prepared in 10 mM phosphate buffer and diluted together with PLP to give a mixed PLP and PA standard (25 mgal PLP and 50 mgal PA). For the purpose of peak identi®cation PL, PM, PN and PMP were prepared individually and mixed with PLP and PA at ®nal working concentrations of 25 mgal.
Human volunteers and ethics
The study was approved by the Institute of Food Research's Ethics Committee prior to recruitment of volunteers. All volunteers consented to have blood samples taken by a fully quali®ed phlebotomist and record food intake after full explanation of study and any risks involved. Adolescents (13 ± 14 years, n 51, 18 Males, 33 Females) were recruited from two local authority schools. Adults (20 ± 64 y, n 131, 64 males, 67 females) were recruited by written invitation, at random from the General Practitioners' lists of two local Health Centres (Norwich and Dereham). Non-institutionalized elderly volunteers (68 ± 73 years, n 68 29 males, 39 females) and aged volunteers (74 ± 90 y, n 44, 15 males, 29 females) were randomly selected from the ageagender registers of two General Practitioners in Norwich and recruited by written invitation. Recruitment methods are described in full detail by Wright et al, (1995) .
Sample preparation
Fresh, fasting (12 h) venous, whole blood was removed by venepuncture into heparinized plastic tubes (Sarstedt, Leicester, UK), centrifuged (5006g, 4 C, 10 min) and 500 ml of plasma removed into 2 ml plastic microfuge tubes (Sarstedt, Leicester, UK) which were stored at À40 C until analysis.
Derivatisation
Derivatisation of samples was performed under non-UV lighting. Duplicate aliquots (100 ml) of thawed plasma were pipetted into further microfuge tubes containing aqueous potassium phosphate buffer (100 ml, 10 mM; pH 7.4) and deproteinized by the addition of trichloroacetic acid (TCA; 200 ml, 10% wav). The samples were capped and heated for 15 min at 50 C. After cooling to room temperature (20 ± 25 C), dipotassium phosphate (140 ml, 3.3 M; pH 10.2) and potassium cyanide (40 ml, 8 mM) were added, mixing tube contents after each addition. The cyanide derivatives of PLP and PA were formed by heating again at 50 C for 25 min. After again cooling to room temperature thē uorescent derivatives were stabilized by addition of phosphoric acid (50 ml, 28%). Samples were centrifuged at 88006g for 5 min and the supernatants transferred to amber, crimp cap, auto sampler vials for HPLC analysis.
Chromatographic conditions
The analytical HPLC column was an Apex TM 3 mm ODS (C18) I, 2560.4 cm id. (Jones Chromatography, Mid Glamorgan, UK) instead of that used by Naoi et al (1988) , (STR TM ODS-H; 150 mm64 mm id; 5 mm particle size; 100 A Ê pore size). Samples (50 ml) were injected by loop ®lling using a Rheodyne TM 7125 valve (Anachem, Luton, Bedfordshire, UK). The analytical column was protected by use of a guard column packed with 40 mm C18 material 2 cm62 mm id, Anachem, Luton, UK). The HPLC pump used was isocratic (SA 6410B, Severn Analytical, Hitchin Beds, UK). The mobile phase was 1 mM heptane sulphonic acid in 2 M potassium acetate, adjusted to pH 3.75 with potassium hydroxide (solid). The¯ow rate was 1.0 mlamin. The column temperature was ambient. Following separation, cyanide derivatives were detected¯uorometrically using a LS 5 luminescence spectrophotometer (Perkin Elmer, Buckinghamshire, UK). Excitation and emission wavelengths were 318 and 418 nm respectively. Concentrations of PLP or PA were calculated by comparison of peak heights with those of standard solutions following collection of data using APEX Chromatography data collection system (Severn Analytical, Hitchin, Beds, UK). A Kromasil TM 5 mm ODS I (15 cm60.4 mm id; BAS Technicol, Stockport, UK) analytical column was also tested as an alternative to the Apex column mentioned above.
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Sample stability and quality control Recovery of PLP from plasma samples was determined by analysing plasma with and without the addition of working standard before derivatization, to give a spike PLP concentration of 12.5 mgal plasma (50.6 nM). Recoveries were calculated as (spiked value minus unspiked value) as a percentage of the unspiked value.
The possibility of establishing a quality control system for routine daily use was investigated. Pooled, fresh, heparinized, whole blood (total volume 100 ml) was centrifuged (10 min; 500 g force), the plasma removed, pooled and mixed gently to ensure homogeneity. Aliquots (100 ml) of this pooled plasma were stored in plastic microfuge tubes (2 ml, Sarstedt, Leicester UK), under liquid nitrogen and removed at intervals of up to 16 months for PLP analysis. These QC samples were also used to measure between assay coef®cient of variation.
Vitamin B 6 intakes Vitamin B 6 intakes for the populations described in this study were measured by 5 ± 7d weighed dietary records and calculated from food tables. Detailed description of the methods used are described elsewhere (Wright et al, 1995; Southon et al, 1992) . Vitamin B 6 intakes were expressed as mgamg of protein consumed and compared to reference nutrient intakes (RNI), estimated average requirements (EAR) and lower reference nutrient intakes (LRNI) for the relevant population age group (Department of Health, 1991) . Percentages of each population with vitamin B 6 intakes below each of these cut-offs were calculated.
Statistical methods
Linearity of PLP calibration curves was tested by regression analysis. The distribution of values for both plasma PLP concentration (nM) and vitamin B 6 intake (mgag protein intake) were normalized by mathematical (log 10 ) transformation prior to further statistical investigation. Mean (log 10 ) PLP concentrations and vitamin B 6 intakes were compared, within gender, by one-way analysis of variance (1-ANOVA). Following a signi®cant (P`0.05) variance ratio (F-test), any differences between mean values for the four age groupings (adolescent, adult, elderly and aged) were determined by the post-hoc application of the Scheffe Â test. Female values were compared to those of their male counterparts by Student's unpaired t-test. Within gender; relationships, if any, between plasma PLP concentrations (log 10 ) and vitamin B 6 intakes (log 10 ) were assessed using linear regression analysis.
Results
Chromatographic separation
The chromatographic separation of pyridoxal-5-phosphate (PLP), pyridoxic acid (PA), pyridoxamine (PM) and pyridoxamine-5-phosphate (PMP), as their cyanide derivatives, is shown in Figure 1 . Pyridoxal (PL) and pyridoxine (PN) did not produce a¯uorescence response at concentrations of 25 mgal. Both PM and PMP gave ā uorescence response, but not at suf®cient sensitivity to allow determination of these forms of vitamin B 6 in plasma samples. A typical chromatogram of a derivatised plasma sample is shown in Figure 2 .
The data given in this paper were achieved using an Apex TM I column (Jones Chromatography, Mid Glamorgan, UK) instead of the STR ODS H (Shimadzu, Japan) analytical column used by Naoi et al, (1988) . Both the Apex TM or a tromasil TM ODS I were found to adequately separate the forms of vitamin B 6 with no noticeable differences in resolution.
Linearity, recovery, variability and detection limit Calibration curves (0, 5, 10, 15, 20, 25 ngaml) . The mean recovery of added PLP from plasma was 92.8% (n 10, CV 2.03%; range 89.7% ± 96.6%). The within assay coef®cient of variation for plasma was 2.8% (n 10, meanÀ11.19 mgal (45.32 nM)). The between assay coef®cient of variation (CV), calculated from analysis of QC samples over a three month period was 5.2% (n 17, mean 13.84 mgal (56.05 nM)). Similarly at higher PLP concentrations over 9 months CV 5.7% (n 5, mean-À23.82 mgal (96.47 nM). The detection limit for plasma PLP, calculated as three times chromatographic base line noise, was 2 mgal (8 nM). 
Sample stability
Linear regression analysis of data from 3 QC batches of human plasma, stored under liquid nitrogen (À196 C) for 3, 9 and 16 months, indicated no signi®cant loss of PLP with time.
Plasma PLP concentrations in human volunteers
Log 10 mean and standard deviation (s.d.), together with geometric mean and range (min ± max), of PLP concentrations found in adolescent, adult, elderly and aged volunteers, and the percentage of subjects with plasma PLP levels indicative of inadequate vitamin B 6 status (`34.4 nM; Rose et al, 1976) , are shown in Table 1 . Aged males (b73 y) had signi®cantly (P`0.05) higher PLP concentrations than all their younger counterparts, between which there were no signi®cant differences. There were no differences between the female age groups, or between males and females at any age.
Vitamin B 6 intakes Log 10 mean and s.d., together with geometric mean and range (min ± max) of vitamin B 6 intakes (mgad) for adolescent, adult, elderly and aged populations are shown in Table 2 . The same data, expressed as mgag protein intake, are shown in Table 3 . Percentages of each population with vitamin B 6 intakes below reference nutrient intakes (RNI; 1.2 mgad for adolescent males; 1.0 mgad for adolescent females; 1.4 mgad for adult, elderly and aged males; 1.2 mgaday for adult, elderly and aged females; 15 mgag protein intake for all populations), estimated average requirements (EAR; 13 mgag protein intake) and lower reference nutrient intakes (LRNI; 11 mgag protein intake) (Department of Health, 1991) are also shown in Tables 2  and 3 as appropriate.
When expressed as total vitamin B 6 intake (mgaday) adult males had signi®cantly higher (P`0.001) intakes than younger or older male volunteers, and sign®cantly higher (P`0.05) intakes than adult females. Aged females had signi®cantly lower (P`0.001) vitamin B 6 intakes than adult females, and lower (P`0.05) than their male counterparts. When expressed as mgag protein intake, there were no differences between the male age groups in vitamin B 6
Figure 2 HPLC chromatogram of a derivatised plasma sample, showing pyridoxal-5-phosphate (PLP) and pyridoxic acid (PA). Chromatographic conditions are described in the methods section. (Rose et al, 1976 ), but we suggest that this cut-off was placed arbitrarily. {Geometric mean; i.e. antilog 10 of log 10-mean. abc (xyz): Within males (abc) or females (xyz), means not sharing a common superscript are signi®cantly (P`0.05) different; Post-Hoc Scheffe Â test. {Though Variance Ratio is signi®cant, the Post-Hoc Scheffe Â test indicates no difference between individual means. Note: Female means are not signi®cantly different (P`0.05) from their corresponding male means; Student's unpaired t-test. {{Means and s.d. of log 10-transformed data, geometric mean, ranges (min-max) and apparent percentage of subjects at risk of vitamin B 6 de®ciencyx.
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Expressed as mgad quite large percentages of all subjects (26 ± 69%) had intakes of vitamin B 6 that were low in comparison with the RNI (there is no LRNI as mgad) but when expressed in terms of protein intake, only a small percentage of aged ( b 73 y) volunteers, of both genders, had a tendency to fall below the LRNI (11 mgag protein intake for vitamin B 6 intake.
Comparison of PLP concentrations with vitamin B 6 intakes
There was no signi®cant statistical degree of association between log 10 PLP concentration and log 10 vitamin B 6 intake for either gender in any age group, whether vitamin B 6 intakes were expressed as mgad or mgag protein intake.
Discussion
The method
The production of a cyanide derivative of pyridoxal-5-phosphate (PLP) has been applied successfully to human plasma samples. The method is sensitive (requiring only 100 ml of plasma), rapid (elution time reduced tò 5 min), reproducible (2.8% coef®cient of variation) and does not require speci®c anti-coagulants, offering an alternative to apo-enzyme methods for the routine determination of vitamin B 6 status. x: Reference nutrient intake (RNI) 15 mgag protein intake, estimated average requirement (EAR) 13 mgag protein intake, and lower reference nutrient intake (LRNI) 11 mgag protein intake; (Department of Health, 1991) . { Geometric mean; i.e. antilog 10 of log 10-mean. abc (xyz): Within males (abc) or females (xyz), means not sharing a common superscript are signi®cantly (P`0.05) different; Post-Hoc Scheffe Â test. {Though Variance Ratio is signi®cant, the Post-Hoc Scheffe Â test indicates no difference between individual means. *Female mean is signi®cantly different (P`0.05) from its corresponding male mean; Student's unpaired t-test. {{Means and s.d. of log 10-transformed data, geometric mean, ranges (min-max) and apparent percentage of subjects with intakes below RNIx, EARx and LRNx
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The chromatographic separation of PLP and PA cyanide derivatives (Figure 1 ), illustrates that pyridoxic acid (PA) might also be determined by the method described here. PMP and PM, although shown to produce¯uorescent cyanide derivatives (Figure 1 ), were not found in plasma samples at detectable levels (`2 mgal). Other forms of vitamin B 6 (PL, PN) did not appear to produce cyanide derivatives under the conditions used, although PL has previously been demonstrated to react with cyanide under alkaline conditions to give a¯uorescent product (Ohishi & Fukui, 1968) . The measurement of PLP alone, however, was the purpose of the method presented, since it is known to be the active coenzyme form of vitamin B 6 in plasma. The detection limit of 2 mgal (8 nM) could be lowered considerably by use of a`state of the art' HPLC¯uores-cence detector.
Sample stability and quality control Pooled plasma samples were found to be stable for at least 16 months, with respect to PLP concentrations, when stored under liquid nitrogen. Borschel et al (1987) found plasma PLP to be stable for up to 2 y when stored in the dark at À30
C, but the radio-enzyme kit for PLP (Buhlmann Laboratories AG, Basel, Switzerland) states that EDTA plasma remains stable at À20 C for only up to 4 weeks. If pooled plasma samples can be aliquoted into small volumes and stored at À30 C or less, it would appear that these make a suitable in-house quality control material. For quality control between laboratories, samples would have to be transported under carefully controlled conditions. Future investigations should include studies of the effects of storage and handling of samples in typical hospital ®eld study conditions.
Plasma PLP concentrations in human population groups
Many studies have found reduced indices of vitamin B 6 status with age (Bitsch, 1993) but in the aged volunteers here, (b 73 y) males had signi®cantly increased mean PLP concentrations when compared to younger age groups and there was no evidence of lower plasma PLP in other elderly groups, when compared to younger groups. A possible reason for this discrepancy might be that the elderly and aged population groups studied here were all free-living and, therefore excluded the portion of elderly of poorest health (institutionalised or hospitalised), whereas some other studies include, or concentrate, on elderly of poor health (Bitsch, 1993) . The volunteers used by Rose et al (1976) were also free living but the great diversity in general`state of health' of elderly populations make it dif®cult to compare measurements between studies without more precise details of the health records of the volunteers.
Clinical manifestations of vitamin B 6 de®ciency are reported to be rare, since the vitamin is found widely distributed in foods, and yet several groups within the population have been described as having low biochemical indices of vitamin B 6 status. Examples include women during pregnancy and lactation (Vir et al, 1980; Guilarte, 1993) , adolescents (Korede & Ajayi, 1991) , and the freeliving, low-income elderly (Manore et al, 1989) . The adolescent, adult and free-living elderly populations studied, using the modi®ed method described in this paper, show considerable proportions of the volunteers to be at risk of de®ciency when PLP concentrations are compared to the currently used cut-off value for indication of vitamin B 6 de®ciency (8.5 mgal (34.4 nM); Rose et al, 1976) .
Intakes of vitamin B 6 for the same volunteers, expressed in terms of protein intake (as recommended by the Department of Health (1991)) however, do not indicate that the population groups studied are at the risk of vitamin B 6 de®ciency, as indicated by PLP values. For all age groups the mean intake is above the RNI of 15 mgag protein, suggesting that on the whole these populations were consuming suf®cient B 6 . Only one adult (female) and four aged volunteers (3 females and 1 male) consumed less than the LRNI, and thus were probably consuming inadequate amounts of vitamin B 6 . However, if vitamin B 6 intakes are expressed without reference to protein intake, quite large percentages of all the groups studied appeared to be consuming inadequate amounts of vitamin B 6 when compared to the RNI. It should be noted that the RNI and LRNI are based on very few studies (Department of Health, 1991) . Although plasma PLP concentrations are believed to re¯ect short-term (a few days) intake, in this study no relationship was found between vitamin B 6 intake and plasma PLP for either gender in any age group, whether vitamin B 6 intakes were expressed as mgad or mgag protein intake. As part of a larger study the vitamin B 6 intakes in the adolescent group were measured by direct analysis of foods (for concentrations of pyridoxamine, pyridoxal, and pyridoxine; the three major forms of vitamin B 6 in food; Brubacher et al, 1986) and were compared with those determined by weighing and calculating from food table data (Southon et al, 1992) . No signi®cant correlation was found between vitamin B 6 intakes obtained by direct analysis and those obtained by calculation, and analysed values were signi®cantly lower; possibly because nonspeci®c microbiological methods for B 6 content were used in food table data (Paul & Southgate, 1978) . This is still largely true of the latest edition of the food tables (Holland et al, 1991) since only a portion of the data has been produced by more modern HPLC methods. Using directly analysed vitamin B 6 intakes no correlation was found between intake and plasma PLP values in female adolescents, but there was a signi®cant correlation for boys (r 0.56, P`0.05; Southon et al, 1994 , Bailey et al, 1997 . Schuster et al (1984) found a positive correlation between PLP and vitamin B 6 intake from the previous day.
Vitamin B 6 intakes when expressed as total mgad were higher for males than females, but the difference was only signi®cant for adult and aged populations. Since males consume more weight of food than females (Department of Health, 1991) , one would expect mgad vitamin B 6 intakes to be higher. When expressed per gram of protein, the present study shows females to consume more vitamin B 6 than males in all age groups except the aged. This suggests that females consume a more vitamin B 6 dense diet than males. The intake results have been expressed both as mgad and mgad protein since the authors consider that the recommendations of the Department of Health (1991) should be considered, even if based on limited data.
That such large numbers of an apparently healthy population (consuming apparently adequate amounts of vitamin B 6 ) should be at risk of vitamin B 6 de®ciency is worrying. One explanation could be that intakes calculated from food tables are an over estimation of actual intake, as was found by comparison of calculated and analysed intake for adolescents (Southon et al, 1992) . If this is the case, and the numbers of volunteers at risk of de®ciency is real, then the B 6 nutrition of the population studied is a cause for concern. However, a consideration of the way in which the Plasma PLP by HPLC AL Bailey et al cut-off value for plasma PLP was established, throws doubt upon how appropriate the value is for judging vitamin B 6 adequacy. The 34.4 nM cut-off was placed arbitrarily at the lower end of reference ranges for normal healthy male subjects aged 18 to 90 y and was described by the authors (Rose et al, 1976) as classifying 30% of their unsupplemented subjects as having marginal, or inadequate, B 6 status. Thus, it would be expected that use of this cut-off value would indicate a similar percentage of subjects with inadequate PLP concentrations in other healthy populations. We suggest that if plasma PLP is to be considered as a routine measure of vitamin B 6 nutrition, that more meaningful cut-off values for judgement of de®ciency needs to be established. This 34.4 nM PLP cut-off value continues to be quoted and often acts as the basis for judgement of vitamin B 6 adequacy (Gibson, 1990) . Leklem (1990) suggests a cut-off of 30 nM PLP, but this still de®nes large percentages of the population as at risk of vitamin B 6 de®ciency. If plasma PLP is to be of any use as a measure of vitamin B 6 adequacy, either alone or together with another index such as an enzyme activation assay, further work must be done to establish a meaningful cut-off value against which PLP results for population groups can be compared.
[It must be noted that the reference ranges given by Rosalind Gibson (1990) are erroneous in that an incorrect molecular weight appears to have been used in converting the values of Rose et al (1976) : 8.5 mgal is equivalent to 34.4 nM and not 50.8 nM as quoted by Gibson (1990) ].
Conclusion
A modi®ed HPLC ±¯uorescence technique has been applied to the analysis of pyridoxal-5-phosphate (PLP), the predominant active form of vitamin B 6 in human plasma. The modi®ed method gives good recoveries of added PLP and small variability, requiring only 100 ml of plasma for analysis. The chromatographic elution time of less than 5 min enables a high sample throughput (20 ± 30 samplesad) and is highly suited to automatic sample injection.
Plasma PLP concentrations are given for adolescent, adult, elderly and aged human population groups. Percentages of subjects with PLP levels below the 34.4 nM cut-off would appear to indicate that large proportions of the apparently healthy population within this community are at risk of vitamin B 6 de®ciency. This was not re¯ected by vitamin B 6 intakes calculated from food tables, but these are possibly an over-estimation of actual intake. However, the cut-off value for plasma PLP was placed arbitrarily and evidence to date indicates it is set too high.
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